Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap Down After Earnings Miss

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS)’s stock price gapped down prior to trading on Tuesday following a weaker than expected earnings announcement. The stock had previously closed at $23.83, but opened at $22.91. Kestra Medical Technologies shares last traded at $23.34, with a volume of 29,702 shares trading hands.

The company reported ($1.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.64) by ($0.61). During the same period last year, the business posted ($1.18) earnings per share.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on KMTS shares. Wolfe Research began coverage on shares of Kestra Medical Technologies in a research note on Monday, March 31st. They set an “outperform” rating and a $29.00 price target for the company. The Goldman Sachs Group started coverage on shares of Kestra Medical Technologies in a research note on Monday, March 31st. They issued a “neutral” rating and a $24.00 price objective for the company. Stifel Nicolaus initiated coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They issued a “buy” rating and a $28.00 price target on the stock. Bank of America assumed coverage on shares of Kestra Medical Technologies in a research note on Monday, March 31st. They set a “buy” rating and a $30.00 price objective on the stock. Finally, Wells Fargo & Company began coverage on shares of Kestra Medical Technologies in a report on Monday, March 31st. They issued an “overweight” rating and a $28.00 price target on the stock. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $27.67.

Kestra Medical Technologies Stock Down 2.1 %

About Kestra Medical Technologies

We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.